Showing results (151-160 of 167) with videos related to
Sort By:
Pageof 17
Scientific Reports|July 24, 2019
Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected LiverW M H d'Avigdor, M A Budzinska, M Lee, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulinG W McCaughan, J Spencer, D Koorey, et al.The American Journal of Pathology|October 9, 1999
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosisP S Haber, G W Keogh, M V Apte, et al.Gut|November 2, 2010
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BS J Patterson, J George, S I Strasser, et al.Alimentary Pharmacology & Therapeutics|March 27, 2014
Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flareV Nguyen, P K Tan, A-J Greenup, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysisM F Silva, G Sapisochin, S I Strasser, et al.Immunological Reviews|May 12, 2000
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant toleranceG W McCaughan, M D Gorrell, G A Bishop, et al.Journal of Viral Hepatitis|January 27, 2015
Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infectionT Tu, W S Mason, A D Clouston, et al.Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.BMC Microbiology|April 16, 2021
Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse modelJ Behary, A E Raposo, N M L Amorim, et al.Pageof 17